Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report released on Saturday morning. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

Ampio Pharmaceuticals stock opened at $0.00 on Friday. The company’s 50-day moving average price is $0.02 and its two-hundred day moving average price is $0.02. The stock has a market cap of $2,964.00, a price-to-earnings ratio of 0.00 and a beta of 3.71. Ampio Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $2.47.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.